| EQ Resources Limited (EQR) ORDINARY FULLY PAID |
Materials |
$1,100 |
Cleansing Notice
|
11 Feb 2026 9:50AM |
$0.210 |
$0.230 |
risen by
9.52%
|
|
| Chrysos Corporation Limited (C79) ORDINARY FULLY PAID |
Industrials |
$897 |
Notice of 1H26 Result
|
11 Feb 2026 9:50AM |
$7.600 |
$7.700 |
risen by
1.32%
|
|
| Thorney Opportunities Ltd (TOP) ORDINARY FULLY PAID |
Financials |
$110 |
Update - Notification of buy-back - TOP
|
11 Feb 2026 9:50AM |
$0.665 |
$0.645 |
fallen by
3.01%
|
|
| WAM Strategic Value Limited (WAR) ORDINARY FULLY PAID |
Financials |
$210 |
Dividend/Distribution - WAR
|
11 Feb 2026 9:50AM |
$1.145 |
$1.165 |
risen by
1.75%
|
|
WAR - Price-sensitive ASX Announcement
Full Release
Key Points
- Dividend distribution of AUD 0.0325 per share.
- Fully franked dividend at 30% corporate tax rate.
- Relates to period ending 31 December 2025.
- Payment date is 29 May 2026.
- Ex-dividend date is 1 May 2026.
- Record date is 4 May 2026.
- DRP applicable with shares issued based on VWAP.
- DRP election deadline is 6 May 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EQ Resources Limited (EQR) ORDINARY FULLY PAID |
Materials |
$1,100 |
Application for quotation of securities - EQR
|
11 Feb 2026 9:49AM |
$0.210 |
$0.230 |
risen by
9.52%
|
|
| Kaiser Reef Limited (KAU) ORDINARY FULLY PAID |
Materials |
$197 |
Union Hill Waste Dump Drilling Results & Stockpile Estimate
|
11 Feb 2026 9:49AM |
$0.330 |
$0.330 |
fallen by
0%
|
|
KAU - Price-sensitive ASX Announcement
Full Release
Key Points
- Drilling at Union Hill consisted of 163 holes over 2212 meters.
- The stockpile at Union Hill is estimated at 0.57 million tonnes at 0.48 g/t Au.
- The material is being processed at the Porcupine Flat Processing Plant.
- Further investigations are underway at the Nuggetty deposit.
- Kaiser Reef is active in both Victoria and Tasmania with significant gold resources.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Thorney Technologies Ltd (TEK) ORDINARY FULLY PAID |
Financials |
$47 |
Update - Notification of buy-back - TEK
|
11 Feb 2026 9:47AM |
$0.130 |
$0.125 |
fallen by
3.85%
|
|
| AuKing Mining Limited (AKN) ORDINARY FULLY PAID |
Materials |
$15 |
Update - Proposed issue of securities - AKN
|
11 Feb 2026 9:45AM |
$0.013 |
$0.012 |
fallen by
7.69%
|
|
| HighCom Limited (HCL) ORDINARY FULLY PAID |
Industrials |
$24 |
Proposed issue of securities - HCL
|
11 Feb 2026 9:44AM |
$0.225 |
$0.190 |
fallen by
15.56%
|
|
| HighCom Limited (HCL) ORDINARY FULLY PAID |
Industrials |
$24 |
Placement and Share Purchase Plan
|
11 Feb 2026 9:44AM |
$0.225 |
$0.190 |
fallen by
15.56%
|
|
HCL - Price-sensitive ASX Announcement
Full Release
Key Points
- HighCom Limited (ASX:HCL) is undertaking a capital raise through a Placement and a Share Purchase Plan (SPP).
- The Placement includes two tranches: Tranche 1 with 25,670,667 shares raising approximately A$5.1 million and Tranche 2 with 9,329,333 shares raising approximately A$1.9 million, subject to shareholder approval.
- The offer price for the Placement represents a discount to the company's recent trading prices.
- The shares issued under the Placement will utilize the company's existing placement capacity and will rank equally with existing shares.
- Directors are participating in the Placement subject to shareholder approval.
- The Placement was managed by Henslow Pty Ltd and Morgans Corporate Limited, with a fee of 5% of the funds raised.
- The SPP offers eligible shareholders the opportunity to purchase up to A$30,000 worth of new shares at the same price as the Placement without incurring transaction costs.
- The SPP is expected to raise up to an additional A$1 million.
- The timeline for these events spans from February to April 2026, with specific dates for allotment, settlement, and trading commencement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Element 25 Limited (E25) ORDINARY FULLY PAID |
Materials |
$85 |
Element 25 Progresses Butcherbird Expansion Project
|
11 Feb 2026 9:44AM |
$0.365 |
$0.320 |
fallen by
12.33%
|
|
E25 - Price-sensitive ASX Announcement
Full Release
Key Points
- Element 25 is expanding Butcherbird Project to 1.1Mtpa production.
- Project supports steel markets and HPMSM facility in Louisiana, USA.
- NAIF approved AU$50 million debt facility for the project.
- Mechanical completion and commissioning targeted for Q1 CY2027.
- Construction contracts to be awarded in April 2026.
- Microsoft Dynamics 365 selected for ERP system implementation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Greenvale Energy Limited (GRV) ORDINARY FULLY PAID |
Energy |
$22 |
Regional Discovery Potential
|
11 Feb 2026 9:44AM |
$0.040 |
$0.038 |
fallen by
5%
|
|
GRV - Price-sensitive ASX Announcement
Full Release
Key Points
- Greenvale Energy Limited has enhanced exploration potential at the Oasis Uranium Project in Queensland.
- Sentinel-2 multi-spectral data reveals gas anomalies associated with uranium.
- These anomalies correlate with previous exploration results, increasing confidence in prospectivity.
- Nine priority exploration areas have been identified for follow-up field work.
- Additional areas of interest identified due to helium, radon, and chlorite anomalies.
- The combined data sets suggest a strong regional discovery potential within EPM 27565.
- Fieldwork is scheduled to commence in Q1 2026, focusing on geological mapping and sampling.
- Permitting notices have been submitted to commence next exploration stages.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Paradigm Biopharmaceuticals Limited (PAR) ORDINARY FULLY PAID |
Health Care |
$128 |
Published Canine Study Strengthens iPPS Phase 3 Rationale
|
11 Feb 2026 9:43AM |
$0.310 |
$0.295 |
fallen by
4.84%
|
|
PAR - Price-sensitive ASX Announcement
Full Release
Key Points
- Peer-reviewed study published in PLOS ONE
- PPS shows sustained pain reduction and improved function in dogs
- MRI and biomarkers indicate slowed cartilage degradation
- Study provides translational model for human osteoarthritis
- Supports Paradigm's ongoing Phase 3 iPPS program
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Retail Food Group Limited (RFG) ORDINARY FULLY PAID |
Consumer Discretionary |
$68 |
Notification of cessation of securities - RFG
|
11 Feb 2026 9:43AM |
$1.170 |
$1.070 |
fallen by
8.55%
|
|
| Wildcat Resources Limited (WC8) ORDINARY FULLY PAID |
Materials |
$556 |
WILDCAT INTERCEPTS SPODUMENE IN ALL HOLES AT BOLT CUTTER
|
11 Feb 2026 9:43AM |
$0.370 |
$0.410 |
risen by
10.81%
|
|
WC8 - Price-sensitive ASX Announcement
Full Release
Key Points
- Wildcat Resources Limited owns 100% of the Tabba Tabba Project mining leases and LCT rights to E45/6205.
- The Bolt Cutter Central pegmatites are interpreted to form a NW trending swarm.
- Spodumene is confirmed within the pegmatites at Bolt Cutter Central.
- There were no significant prior explorations at Bolt Cutter Central before Wildcat's involvement.
- Drilling at Bolt Cutter Central is scheduled to continue with RC and diamond drilling.
- Initial metallurgical testwork and environmental studies are ongoing at Bolt Cutter Central.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Energy Transition Minerals Ltd (ETM) ORDINARY FULLY PAID |
Materials |
$253 |
Change in substantial holding
|
11 Feb 2026 9:43AM |
$0.115 |
$0.115 |
fallen by
0%
|
|
| Dalaroo Metals Ltd (DAL) ORDINARY FULLY PAID |
Materials |
$21 |
Proposed issue of securities - DAL
|
11 Feb 2026 9:42AM |
$0.062 |
$0.065 |
risen by
4.84%
|
|
| Terra Metals Limited (TM1) ORDINARY FULLY PAID |
Materials |
$332 |
New Thick Ti-V-Ga Discovery Across Southwest SW3 and SW4
|
11 Feb 2026 9:41AM |
$0.365 |
$0.420 |
risen by
15.07%
|
|
TM1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant discovery of Ti-V-Ga at the Dante Project in SW3 and SW4.
- High-grade magnetite reef packages up to 60 meters thick.
- Mineralisation confirmed over 800 meters of strike and 400 meters of width.
- Potential to extend at least 1.8km x 0.8km in strike and width.
- Gallium enrichment adds a critical metals dimension.
- Maiden Mineral Resource Estimate expected in 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BSA Limited (BSA) ORDINARY FULLY PAID |
Industrials |
$20 |
Change in substantial holding
|
11 Feb 2026 9:41AM |
$0.220 |
$0.270 |
risen by
22.73%
|
|
| Great Dirt Resources Limited (GR8) ORDINARY FULLY PAID |
Materials |
$23 |
Proposed issue of securities - GR8
|
11 Feb 2026 9:41AM |
$0.235 |
$0.615 |
risen by
161.70%
|
|
| Golden Mile Resources Ltd (G88) ORDINARY FULLY PAID |
Materials |
$5 |
Sampling Confirms Exciting New Gold Target at Pearl Project
|
11 Feb 2026 9:41AM |
$0.008 |
$0.008 |
fallen by
0%
|
|
G88 - Price-sensitive ASX Announcement
Full Release
Key Points
- Follow-up rock chip sampling confirmed gold potential at Aurora Prospect.
- High gold values included 38.7g/t and 29.5g/t.
- Significant gold footprint identified over 800m strike and 200m width.
- Geology suggests a potential low-temperature porphyry system.
- Next steps include further sampling and drilling preparation for September 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Great Dirt Resources Limited (GR8) ORDINARY FULLY PAID |
Materials |
$23 |
Firm Commitments Received for $1.446 Million - Placement
|
11 Feb 2026 9:41AM |
$0.235 |
$0.615 |
risen by
161.70%
|
|
GR8 - Price-sensitive ASX Announcement
Full Release
Key Points
- $1.446 million in firm commitments received for the placement.
- The placement was made at a 24% discount to the 15-day VWAP.
- Funds will be used for existing projects, working capital, and new opportunities.
- 9,333,333 new shares issued at $0.155 each, managed by Westar Capital.
- Steve Parsons and Michael Naylor appointed as consultants.
- Performance rights to be issued, pending shareholder approval.
- The placement does not require shareholder approval under ASX rules.
- Ends trading halt requested on 9 February 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Retail Food Group Limited (RFG) ORDINARY FULLY PAID |
Consumer Discretionary |
$68 |
Notification of cessation of securities - RFG
|
11 Feb 2026 9:40AM |
$1.170 |
$1.070 |
fallen by
8.55%
|
|
| Cettire Limited (CTT) ORDINARY FULLY PAID |
Consumer Discretionary |
$185 |
H1 FY26 Results and Investor Briefing Details
|
11 Feb 2026 9:38AM |
$0.560 |
$0.485 |
fallen by
13.39%
|
|
| Actinogen Medical Limited (ACW) ORDINARY FULLY PAID |
Health Care |
$147 |
ACW receives further $1.9m FY2025 R&D rebate from ATO
|
11 Feb 2026 9:37AM |
$0.043 |
$0.043 |
fallen by
1.16%
|
|
ACW - Price-sensitive ASX Announcement
Full Release
Key Points
- Actinogen Medical Limited received a $1.9 million R&D tax rebate.
- The rebate pertains to the financial year 2025.
- Total R&D tax rebate for FY2025 is $7.36 million.
- The rebate supports the development of Xanamem, a treatment for Alzheimer's.
- Xanamem works by controlling elevated cortisol levels in the brain.
- The Alzheimer's phase 2b/3 trial is progressing after a positive review.
- Final trial results are expected in November 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.